ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD

C. Estornut (Valencia, Spain), I. Roger (Valencia, Spain), B. Ballester (Valencia, Spain), P. Ribera (Valencia, Spain), J. Cortijo (Valencia, Spain)

Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Session: Airway inflammation: pharmacological mechanisms and novel targets
Session type: Thematic Poster
Number: 4216
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
C. Estornut (Valencia, Spain), I. Roger (Valencia, Spain), B. Ballester (Valencia, Spain), P. Ribera (Valencia, Spain), J. Cortijo (Valencia, Spain). ACTIVATION OF NUCLEAR FACTOR ERYTHROID 2-RELATED (Nrf2) SYSTEM AS A NOVEL THERAPEUTIC APPROACH IN COPD. 4216

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
INCREASED MYOSTATIN AS A NEGATIVE REGULATOR OF MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: CLINICAL IMPLICATIONS
Source: Virtual Congress 2020 – Best abstracts in the field of pulmonary rehabilitation
Year: 2020



OBSTACLE OF PHYSICAL ACTIVITY AND ACTIVITIES OF DAILY LIVING IN PATIENTS WITH COPD: DYSPNEA RELATED KINESIOPHOBIA
Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients
Year: 2019


PREVALENCE OF SENSITIZATION TO AVIAN OR FUNGAL PROTEINS IN DIFFERENT WORK ENVIRONMENTS.
Source: International Congress 2018 – Asthma, rhinitis and COPD: cells, mediators, biomarkers and genetics
Year: 2018

MONITORING IMMUNODYNAMICS IN IMMUNE CHECKPOINT INHIBITOR THERAPY FOR STAGE IIIB/IV NON-SMALL CELL LUNG CANCER
Source: International Congress 2018 – Lung cancer: personalised medicine
Year: 2018




ARE THERE CLINICALLY RELEVANT BENEFITS IN A STRUCTURED PROGRAM OF PHYSICAL ACTIVITY IN COPD? ACTIVEPOC STUDY.
Source: Virtual Congress 2020 – Pulmonary rehabilitation across the globe
Year: 2020


DEFICIENT MUSCLE REGENERATION POTENTIAL IN SARCOPENIC COPD PATIENTS: ROLE OF SATELLITE CELLS
Source: International Congress 2019 – Lung function and respiratory muscle testing
Year: 2019

THE ASSOCIATION ANALYSIS OF CHEMILUMINESCENCE OF NEUTROPHILS OF THE BLOOD WITH PATHOGENETIC FACTORS OF COPD
Source: International Congress 2017 – Current molecular and genetic understanding of lung diseases
Year: 2017

DETERMINATION OF EQUATIONS OF THE REFERENCE VALUES FOR THE STATE OF SÃO PAULO POPULATION IN TEST OF INCREMENTAL RESPIRATORY ENDURANCE (TIRE).
Source: International Congress 2019 – New views on testing and training of respiratory muscles
Year: 2019

TRANSCRIPTOMIC PROFILING REVEALS M1-HIGH TUMOUR ASSOCIATED MACROPHAGES THAT ORCHESTRATE THE ADAPTIVE ANTI-TUMOUR RESPONSE IN HUMAN LUNG CANCER
Source: International Congress 2017 – Gene signatures in bronchial diseases
Year: 2017

IS IRON DEFICIENCY MODULATING PHYSICAL ACTIVITY IN COPD?
Source: International Congress 2017 – Best abstracts in physical activity and management of COPD
Year: 2017

PURINERGIC SIGNALING AND LYMPHOID ORGANS ARE INVOLVED IN THE BENEFICIAL EFFECTS OF AEROBIC TRAINING IN ASTHMA
Source: Virtual Congress 2020 – Physiological and cellular mechanisms affecting pulmonary pathologies
Year: 2020


BENEFITS OF MEASURED ISOTIMING IN CONSTANT CARDIOPULMONARY EXERCISE TESTING IN A STRUCTURED PHYSICAL ACTIVITY PROGRAM
Source: Virtual Congress 2020 – Reviews and novel insights into pulmonary rehabilitation
Year: 2020


FACTORS INFLUENCING PHARMACOLOGICAL TREATMENT IN COPD PATIENTS  ENROLED IN AN INTEGRATED DISEASE MANAGEMENT PROGRAMME (IDMP)
Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet?
Year: 2018




EVALUATION OF SMALL AIRWAY DISEASE (SAD) IN ASTHMA. CONCORDANCES AND DISCREPANCES BETWEEN DIFFERENT TECHNIQUES.
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019

INFLUENCE OF INDUCED IMMUNOSUPRESSION ON INFLAMMATION AND LUNGS REMODELING ON THE COPD MODEL
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019


BLOOD PRESSURE EFFECTS OF OBSTRUCTIVE SLEEP APNEA TREATMENT BY CONTINUOUS POSITIVE AIRWAY PRESSURE: SYSTEMATIC REVIEW, METAANALYSIS AND EVALUATION OF PHENOTYPES PREDICTING RESPONSE
Source: International Congress 2019 – Treatment of continuous positive airway pressure and monitoring of its effects
Year: 2019

“A RANDOMISED CONTROLLED STUDY ON EFFECT OF ORAL MAGNESIUM SUPPLEMENTS IN CONTROL OF SYMPTOMS OF BRONCHIAL ASTHMA AND LUNG FUNCTION PARAMETERS”
Source: Virtual Congress 2021 – Asthma clinical trials and real-life studies
Year: 2021


HOME MONITORING WITH A PORTABLE OXYMETER AS AN ALTERNATIVE METHOD TO ASSESS OXYGEN SATURATION DURING DAILY ACTIVITIES IN INTERSTITIAL LUNG DISEASES (ILDs).
Source: International Congress 2019 – The world of idiopathic pulmonary fibrosis
Year: 2019

SLEEP APNOEA AS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR DISEASE: CURRENT EVIDENCE, BASIC MECHANISMS AND RESEARCH PRIORITIES.
Source: Eur Respir J 2007; 29: 614
Year: 2007


COMPARISON OF PHYSICAL PERFORMANCE AND SPIROMETRY VALUES ACCORDING TO FALL RISK OF COPD SUBJECTS
Source: Virtual Congress 2020 – Tapas of respiratory physiotherapy
Year: 2020